GRACE THERAPEUTICS INC(GRCE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRCE GRACE THERAPEUTICS INC

休市中 12-12 16:00:00 EST

3.31

-0.05

-1.49%

盘后3.31

+0.000.00%

16:10 EST

最高3.40	最低3.30	成交量8.67万
今开3.30	昨收3.36	日振幅3.13%
总市值5,122万	流通市值3,094万	总股本1,547万
成交额28.95万	换手率0.93%	流通股本934.85万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRCE","market":"US","secType":"STK","nameCN":"GRACE THERAPEUTICS INC","latestPrice":3.31,"timestamp":1765573200000,"preClose":3.36,"halted":0,"volume":86675,"hourTrading":{"tag":"盘后","latestPrice":3.31,"preClose":3.31,"latestTime":"16:10 EST","volume":4,"amount":13.24,"timestamp":1765573803987},"delay":0,"floatShares":9348500,"shares":15474000,"eps":-0.773304,"marketStatus":"休市中","change":-0.05,"latestTime":"12-12 16:00:00 EST","open":3.3,"high":3.4,"low":3.295,"amount":289513.15246,"amplitude":0.03125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.773304,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1357534800000,"exchange":"NASDAQ","adjPreClose":3.36,"preHourTrading":{"tag":"盘前","latestPrice":3.26,"preClose":3.36,"latestTime":"09:29 EST","volume":857,"amount":2822.5000192,"timestamp":1765549767374},"postHourTrading":{"tag":"盘后","latestPrice":3.31,"preClose":3.31,"latestTime":"16:10 EST","volume":4,"amount":13.24,"timestamp":1765573803987},"volumeRatio":1.4266785186377684},"requestUrl":"/m/hq/s/GRCE/tweets","defaultTab":"tweets","newsList":[{"id":"1174815876","title":"Grace Therapeutics通过普通认股权证行使获得约400万美元，Gtx-104的新药申请已被接受进行正式FDA审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1174815876","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174815876?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:00","pubTimestamp":1761220834,"startTime":"0","endTime":"0","summary":"Grace Therapeutics通过普通认股权证行使获得约400万美元，Gtx-104的新药申请已被接受进行正式FDA审查","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRCE","BK4007"],"gpt_icon":0},{"id":"1178279191","title":"Grace Therapeutics关键性三期Strive-on安全性试验在2025年神经重症医学年会上发表","url":"https://stock-news.laohu8.com/highlight/detail?id=1178279191","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178279191?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:00","pubTimestamp":1758542426,"startTime":"0","endTime":"0","summary":"Grace Therapeutics关键性三期Strive-on安全性试验在2025年神经重症医学年会上发表","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRCE"],"gpt_icon":0},{"id":"1176947072","title":"Grace Therapeutics宣布FDA接受Gtx-104新药申请审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1176947072","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176947072?lang=zh_cn&edition=full","pubTime":"2025-08-27 20:01","pubTimestamp":1756296081,"startTime":"0","endTime":"0","summary":"Grace Therapeutics宣布，美国食品药品监督管理局（FDA）已接受对其Gtx-104新药申请的审查。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRCE","BK4007"],"gpt_icon":0},{"id":"2546237975","title":"Grace Therapeutics, Inc.2025财年实现净利润-9.57百万美元，同比增加25.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546237975","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546237975?lang=zh_cn&edition=full","pubTime":"2025-06-25 02:00","pubTimestamp":1750788007,"startTime":"0","endTime":"0","summary":"6月25日，Grace Therapeutics, Inc.公布财报，公告显示公司2025财年净利润为-9.57百万美元，同比增加25.53%；其中营业收入为0.00美元，每股基本收益为-0.79美元。机构评级：截至2025年6月25日，当前有2家机构对Grace Therapeutics, Inc.目标价做出预测，其中目标均价为11.50美元，其中最低目标价为11.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625020018a4bbe6a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625020018a4bbe6a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GRCE"],"gpt_icon":0},{"id":"1108073478","title":"Grace Therapeutics第三季度每股收益为-0.36美元, 低于预估的-0.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108073478","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108073478?lang=zh_cn&edition=full","pubTime":"2025-02-13 21:09","pubTimestamp":1739452160,"startTime":"0","endTime":"0","summary":"Grace Therapeutics第三季度每股收益为-0.36美元, 低于预估的-0.34美元以上内容来自Benzinga Earnings专栏，原文如下：Grace $Therapeutics(LENZ)$ Q3 EPS $(0.36) Vs $(0.34) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","GRCE"],"gpt_icon":0},{"id":"2485982672","title":"Grace Therapeutics, Inc.2024财年第三财季实现净利润-3.43百万美元，同比减少4.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485982672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485982672?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291227,"startTime":"0","endTime":"0","summary":"11月23日，Grace Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-3.43百万美元，同比减少4.89%；其中营业收入为0.00美元，每股基本收益为-0.30美元。从资产负债表来看，Grace Therapeutics, Inc.总负债9.22百万美元，其中短期债务0.00美元，资产负债比为7.09，流动比率为6.02。机构评级：截至2024年11月23日，当前有3家机构对Grace Therapeutics, Inc.目标价做出预测，其中目标均价为10.83美元，其中最低目标价为8.00美元，最高目标价为12.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000055a24e4853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000055a24e4853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GRCE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gracetx.com","stockEarnings":[{"period":"1week","weight":0.028},{"period":"1month","weight":0.0924},{"period":"3month","weight":0.0508},{"period":"6month","weight":0.1655},{"period":"1year","weight":-0.1513},{"period":"ytd","weight":-0.115}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Grace Therapeutics, Inc.成立于2002年2月1日。他们专注于开发和商业化用于罕见和孤儿疾病的产品，这些产品有可能通过使用他们的新型药物递送技术来改善临床结果。他们寻求将新的专有配方应用于已获批准和上市的药物化合物，以实现增强疗效、更快起效、减少副作用、更方便的药物递送和提高患者依从性。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.035531},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.033972},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.056637},{"month":4,"riseRate":0.230769,"avgChangeRate":-0.036832},{"month":5,"riseRate":0.615385,"avgChangeRate":-0.001291},{"month":6,"riseRate":0.538462,"avgChangeRate":0.01107},{"month":7,"riseRate":0.461538,"avgChangeRate":0.148318},{"month":8,"riseRate":0.076923,"avgChangeRate":-0.157111},{"month":9,"riseRate":0.461538,"avgChangeRate":0.081587},{"month":10,"riseRate":0.153846,"avgChangeRate":-0.11872},{"month":11,"riseRate":0.538462,"avgChangeRate":-0.024598},{"month":12,"riseRate":0.769231,"avgChangeRate":0.068139}],"exchange":"NASDAQ","name":"GRACE THERAPEUTICS INC","nameEN":"GRACE THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRACE THERAPEUTICS INC(GRCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRACE THERAPEUTICS INC(GRCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRACE THERAPEUTICS INC,GRCE,GRACE THERAPEUTICS INC股票,GRACE THERAPEUTICS INC股票老虎,GRACE THERAPEUTICS INC股票老虎国际,GRACE THERAPEUTICS INC行情,GRACE THERAPEUTICS INC股票行情,GRACE THERAPEUTICS INC股价,GRACE THERAPEUTICS INC股市,GRACE THERAPEUTICS INC股票价格,GRACE THERAPEUTICS INC股票交易,GRACE THERAPEUTICS INC股票购买,GRACE THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRACE THERAPEUTICS INC(GRCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRACE THERAPEUTICS INC(GRCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}